tiprankstipranks
Bausch + Lomb Corporation (DE:S2L)
FRANKFURT:S2L
Germany Market

Bausch + Lomb Corporation (S2L) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

S2L Analyst Ratings

Hold
9Ratings
Hold
3 Buy
5 Hold
1 Sell
Based on 9 analysts giving stock ratings to
Bausch
+ Lomb Corporation
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

S2L Stock 12 Month Forecast

Average Price Target

€15.94
▲(13.88% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Bausch + Lomb Corporation in the last 3 months. The average price target is €15.94 with a high forecast of €18.31 and a low forecast of €13.95. The average price target represents a 13.88% change from the last price of €14.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"€9","14":"€14","19":"€19","11.5":"€11.5","16.5":"€16.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18.30950919,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€18.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.942973988571433,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€15.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.95010224,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€13.95</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,11.5,14,16.5,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.1,13.500731476153845,13.901462952307693,14.302194428461538,14.702925904615384,15.103657380769231,15.504388856923077,15.905120333076923,16.30585180923077,16.706583285384614,17.10731476153846,17.50804623769231,17.908777713846156,{"y":18.30950919,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.1,13.318690306813187,13.537380613626373,13.756070920439562,13.974761227252749,14.193451534065936,14.412141840879123,14.63083214769231,14.849522454505497,15.068212761318684,15.28690306813187,15.50559337494506,15.724283681758246,{"y":15.942973988571433,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.1,13.16539248,13.23078496,13.29617744,13.361569919999999,13.426962399999999,13.492354879999999,13.55774736,13.62313984,13.68853232,13.7539248,13.81931728,13.88470976,{"y":13.95010224,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.8,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.6,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.4,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.9,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.6,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.5,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.1,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€18.31Average Price Target€15.94Lowest Price Target€13.95
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on DE:S2L
Stifel Nicolaus
Stifel Nicolaus
€13.95
Hold
-0.36%
Downside
Reiterated
05/21/26
Bausch + Lomb Corporation (BLCO) Receives a Hold from Stifel Nicolaus
H.C. Wainwright Analyst forecast on DE:S2L
H.C. Wainwright
H.C. Wainwright
€17.44
Buy
24.55%
Upside
Reiterated
05/04/26
H.C. Wainwright Remains a Buy on Bausch + Lomb Corporation (BLCO)
Deutsche Bank  Analyst forecast on DE:S2L
Deutsche Bank
Deutsche Bank
€15.69€13.95
Hold
-0.36%
Downside
Reiterated
04/30/26
Bausch + Lomb price target lowered to $16 from $18 at Deutsche BankBausch + Lomb price target lowered to $16 from $18 at Deutsche Bank
RBC Capital Analyst forecast on DE:S2L
RBC Capital
RBC Capital
€18.31
Buy
30.78%
Upside
Reiterated
04/30/26
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Regeneron (REGN)
Barclays Analyst forecast on DE:S2L
Barclays
Barclays
€17.44
Hold
24.55%
Upside
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Align Tech (NASDAQ: ALGN) and Bausch + Lomb Corporation (NYSE: BLCO)
Evercore ISI Analyst forecast on DE:S2L
Evercore ISI
Evercore ISI
€14.82€13.95
Hold
-0.36%
Downside
Reiterated
04/30/26
Bausch + Lomb price target lowered to $16 from $17 at Evercore ISIBausch + Lomb price target lowered to $16 from $17 at Evercore ISI
Bank of America Securities Analyst forecast on DE:S2L
Bank of America Securities
Bank of America Securities
Sell
Reiterated
04/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN), Bausch + Lomb Corporation (NYSE: BLCO) and Indivior (NASDAQ: INDV)
Citi
€18.31€16.57
Buy
18.33%
Upside
Reiterated
04/30/26
Bausch + Lomb price target lowered to C$19 from C$21 at CitiBausch + Lomb price target lowered to C$19 from C$21 at Citi
Needham
Hold
Reiterated
04/29/26
Bausch + Lomb: Solid Q1 Beat and Pharma Momentum Offset by Spin-Off Uncertainty, Supporting Hold Rating
Goldman Sachs Analyst forecast on DE:S2L
Goldman Sachs
Goldman Sachs
€16.57
Hold
18.33%
Upside
Reiterated
03/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Lifecore Biomedical (NASDAQ: LFCR), Pyxis Oncology (NASDAQ: PYXS) and Bausch + Lomb Corporation (NYSE: BLCO)
Morgan Stanley Analyst forecast on DE:S2L
Morgan Stanley
Morgan Stanley
€18.31
Buy
30.78%
Upside
Reiterated
03/03/26
Morgan Stanley Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)
Wells Fargo Analyst forecast on DE:S2L
Wells Fargo
Wells Fargo
€14.82€15.69
Hold
12.10%
Upside
Reiterated
02/19/26
Bausch + Lomb Corporation (BLCO) Receives a Hold from Wells Fargo
J.P. Morgan Analyst forecast on DE:S2L
J.P. Morgan
J.P. Morgan
€11.33€13.95
Hold
-0.36%
Downside
Reiterated
10/30/25
Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on DE:S2L
Stifel Nicolaus
Stifel Nicolaus
€13.95
Hold
-0.36%
Downside
Reiterated
05/21/26
Bausch + Lomb Corporation (BLCO) Receives a Hold from Stifel Nicolaus
H.C. Wainwright Analyst forecast on DE:S2L
H.C. Wainwright
H.C. Wainwright
€17.44
Buy
24.55%
Upside
Reiterated
05/04/26
H.C. Wainwright Remains a Buy on Bausch + Lomb Corporation (BLCO)
Deutsche Bank  Analyst forecast on DE:S2L
Deutsche Bank
Deutsche Bank
€15.69€13.95
Hold
-0.36%
Downside
Reiterated
04/30/26
Bausch + Lomb price target lowered to $16 from $18 at Deutsche BankBausch + Lomb price target lowered to $16 from $18 at Deutsche Bank
RBC Capital Analyst forecast on DE:S2L
RBC Capital
RBC Capital
€18.31
Buy
30.78%
Upside
Reiterated
04/30/26
Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Regeneron (REGN)
Barclays Analyst forecast on DE:S2L
Barclays
Barclays
€17.44
Hold
24.55%
Upside
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Align Tech (NASDAQ: ALGN) and Bausch + Lomb Corporation (NYSE: BLCO)
Evercore ISI Analyst forecast on DE:S2L
Evercore ISI
Evercore ISI
€14.82€13.95
Hold
-0.36%
Downside
Reiterated
04/30/26
Bausch + Lomb price target lowered to $16 from $17 at Evercore ISIBausch + Lomb price target lowered to $16 from $17 at Evercore ISI
Bank of America Securities Analyst forecast on DE:S2L
Bank of America Securities
Bank of America Securities
Sell
Reiterated
04/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN), Bausch + Lomb Corporation (NYSE: BLCO) and Indivior (NASDAQ: INDV)
Citi
€18.31€16.57
Buy
18.33%
Upside
Reiterated
04/30/26
Bausch + Lomb price target lowered to C$19 from C$21 at CitiBausch + Lomb price target lowered to C$19 from C$21 at Citi
Needham
Hold
Reiterated
04/29/26
Bausch + Lomb: Solid Q1 Beat and Pharma Momentum Offset by Spin-Off Uncertainty, Supporting Hold Rating
Goldman Sachs Analyst forecast on DE:S2L
Goldman Sachs
Goldman Sachs
€16.57
Hold
18.33%
Upside
Reiterated
03/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Lifecore Biomedical (NASDAQ: LFCR), Pyxis Oncology (NASDAQ: PYXS) and Bausch + Lomb Corporation (NYSE: BLCO)
Morgan Stanley Analyst forecast on DE:S2L
Morgan Stanley
Morgan Stanley
€18.31
Buy
30.78%
Upside
Reiterated
03/03/26
Morgan Stanley Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)
Wells Fargo Analyst forecast on DE:S2L
Wells Fargo
Wells Fargo
€14.82€15.69
Hold
12.10%
Upside
Reiterated
02/19/26
Bausch + Lomb Corporation (BLCO) Receives a Hold from Wells Fargo
J.P. Morgan Analyst forecast on DE:S2L
J.P. Morgan
J.P. Morgan
€11.33€13.95
Hold
-0.36%
Downside
Reiterated
10/30/25
Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bausch + Lomb Corporation

3 Months
Douglas MiehmRBC Capital
Success Rate
15/28 ratings generated profit
54%
Average Return
+1.52%
Copying Douglas Miehm's trades and holding each position for 3 Months would result in 53.57% of your transactions generating a profit, with an average return of +1.52% per trade.
1 Year
Douglas MiehmRBC Capital
Success Rate
13/28 ratings generated profit
46%
Average Return
+1.66%
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 46.43% of your transactions generating a profit, with an average return of +1.66% per trade.
2 Years
Douglas MiehmRBC Capital
Success Rate
9/28 ratings generated profit
32%
Average Return
-1.03%
Copying Douglas Miehm's trades and holding each position for 2 Years would result in 32.14% of your transactions generating a profit, with an average return of -1.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

S2L Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
7
7
9
7
5
Hold
8
8
14
10
9
Sell
1
1
2
1
1
Strong Sell
0
0
0
0
0
total
16
16
25
18
15
In the current month, S2L has received 5 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. S2L average Analyst price target in the past 3 months is 15.94.
Each month's total comprises the sum of three months' worth of ratings.

S2L Financial Forecast

S2L Earnings Forecast

Next quarter’s earnings estimate for S2L is €0.13 with a range of €0.10 to €0.18. The previous quarter’s EPS was €0.07. S2L beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year S2L has Performed in-line its overall industry.
Next quarter’s earnings estimate for S2L is €0.13 with a range of €0.10 to €0.18. The previous quarter’s EPS was €0.07. S2L beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year S2L has Performed in-line its overall industry.

S2L Sales Forecast

Next quarter’s sales forecast for S2L is €1.19B with a range of €1.18B to €1.19B. The previous quarter’s sales results were €1.08B. S2L beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year S2L has Performed in-line its overall industry.
Next quarter’s sales forecast for S2L is €1.19B with a range of €1.18B to €1.19B. The previous quarter’s sales results were €1.08B. S2L beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year S2L has Performed in-line its overall industry.

S2L Stock Forecast FAQ

What is DE:S2L’s average 12-month price target, according to analysts?
Based on analyst ratings, Bausch + Lomb Corporation’s 12-month average price target is 15.94.
    What is DE:S2L’s upside potential, based on the analysts’ average price target?
    Bausch + Lomb Corporation has 13.88% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Bausch + Lomb Corporation a Buy, Sell or Hold?
          Bausch + Lomb Corporation has a consensus rating of Hold, which is based on 3 buy ratings, 5 hold ratings and 1 sell ratings.
            What is Bausch + Lomb Corporation’s share price target?
            The average share price target for Bausch + Lomb Corporation is 15.94. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €18.31 ,and the lowest forecast is €13.95. The average share price target represents 13.88% Increase from the current price of €14.
              What do analysts say about Bausch + Lomb Corporation?
              Bausch + Lomb Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of Bausch + Lomb Corporation?
                To buy shares of DE:S2L, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.